nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HTR6—Alzheimer's disease	0.289	0.64	CbGaD
Thioridazine—HTR2A—Donepezil—Alzheimer's disease	0.0943	0.285	CbGbCtD
Thioridazine—HTR2A—Alzheimer's disease	0.0849	0.188	CbGaD
Thioridazine—CYP2D6—Alzheimer's disease	0.0777	0.172	CbGaD
Thioridazine—DRD2—Memantine—Alzheimer's disease	0.0754	0.228	CbGbCtD
Thioridazine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0392	0.119	CbGbCtD
Thioridazine—CYP2C19—Memantine—Alzheimer's disease	0.0358	0.108	CbGbCtD
Thioridazine—CYP2C9—Donepezil—Alzheimer's disease	0.0343	0.104	CbGbCtD
Thioridazine—CYP2D6—Donepezil—Alzheimer's disease	0.0314	0.0949	CbGbCtD
Thioridazine—CYP2D6—Galantamine—Alzheimer's disease	0.0202	0.0611	CbGbCtD
Thioridazine—HTR2C—choroid plexus—Alzheimer's disease	0.00824	0.129	CbGeAlD
Thioridazine—HTR2A—choroid plexus—Alzheimer's disease	0.00413	0.0649	CbGeAlD
Thioridazine—HTR7—locus ceruleus—Alzheimer's disease	0.00409	0.0643	CbGeAlD
Thioridazine—Incontinence—Galantamine—Alzheimer's disease	0.00365	0.0442	CcSEcCtD
Thioridazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00311	0.0488	CbGeAlD
Thioridazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00255	0.0401	CbGeAlD
Thioridazine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00241	0.0379	CbGeAlD
Thioridazine—Tardive dyskinesia—Memantine—Alzheimer's disease	0.00241	0.0292	CcSEcCtD
Thioridazine—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.00236	0.0285	CcSEcCtD
Thioridazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00208	0.0327	CbGeAlD
Thioridazine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00203	0.0319	CbGeAlD
Thioridazine—Parkinsonism—Memantine—Alzheimer's disease	0.00198	0.0239	CcSEcCtD
Thioridazine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00194	0.0305	CbGeAlD
Thioridazine—Parkinsonism—Rivastigmine—Alzheimer's disease	0.00193	0.0234	CcSEcCtD
Thioridazine—Neuroleptic malignant syndrome—Donepezil—Alzheimer's disease	0.00193	0.0234	CcSEcCtD
Thioridazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00184	0.0288	CbGeAlD
Thioridazine—Neuroleptic malignant syndrome—Memantine—Alzheimer's disease	0.00175	0.0212	CcSEcCtD
Thioridazine—Sudden death—Memantine—Alzheimer's disease	0.00175	0.0212	CcSEcCtD
Thioridazine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00172	0.0208	CcSEcCtD
Thioridazine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00169	0.0205	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.00131	0.0159	CcSEcCtD
Thioridazine—Torsade de pointes—Memantine—Alzheimer's disease	0.00128	0.0155	CcSEcCtD
Thioridazine—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00128	0.0154	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00121	0.0147	CcSEcCtD
Thioridazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00121	0.019	CbGeAlD
Thioridazine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00119	0.0144	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.00117	0.0141	CcSEcCtD
Thioridazine—Hyperkinesia—Galantamine—Alzheimer's disease	0.00111	0.0135	CcSEcCtD
Thioridazine—HTR6—forebrain—Alzheimer's disease	0.00109	0.0171	CbGeAlD
Thioridazine—Pallor—Memantine—Alzheimer's disease	0.00108	0.0131	CcSEcCtD
Thioridazine—Pallor—Rivastigmine—Alzheimer's disease	0.00106	0.0128	CcSEcCtD
Thioridazine—HTR6—telencephalon—Alzheimer's disease	0.001	0.0157	CbGeAlD
Thioridazine—Abnormal dreams—Donepezil—Alzheimer's disease	0.000977	0.0118	CcSEcCtD
Thioridazine—HTR7—blood vessel—Alzheimer's disease	0.000961	0.0151	CbGeAlD
Thioridazine—Lethargy—Galantamine—Alzheimer's disease	0.000945	0.0114	CcSEcCtD
Thioridazine—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.000868	0.0105	CcSEcCtD
Thioridazine—DRD1—forebrain—Alzheimer's disease	0.000811	0.0127	CbGeAlD
Thioridazine—Hyperkinesia—Memantine—Alzheimer's disease	0.000783	0.00947	CcSEcCtD
Thioridazine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000766	0.00927	CcSEcCtD
Thioridazine—DRD1—telencephalon—Alzheimer's disease	0.000746	0.0117	CbGeAlD
Thioridazine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000701	0.00848	CcSEcCtD
Thioridazine—Lethargy—Memantine—Alzheimer's disease	0.000665	0.00804	CcSEcCtD
Thioridazine—CHRM2—forebrain—Alzheimer's disease	0.000654	0.0103	CbGeAlD
Thioridazine—Psychotic disorder—Memantine—Alzheimer's disease	0.000637	0.0077	CcSEcCtD
Thioridazine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000631	0.00763	CcSEcCtD
Thioridazine—HTR2C—forebrain—Alzheimer's disease	0.00063	0.00989	CbGeAlD
Thioridazine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000623	0.00753	CcSEcCtD
Thioridazine—Asthma—Donepezil—Alzheimer's disease	0.000621	0.0075	CcSEcCtD
Thioridazine—Cardiac arrest—Memantine—Alzheimer's disease	0.00062	0.0075	CcSEcCtD
Thioridazine—Eosinophilia—Donepezil—Alzheimer's disease	0.000614	0.00743	CcSEcCtD
Thioridazine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000606	0.00733	CcSEcCtD
Thioridazine—Sweating increased—Donepezil—Alzheimer's disease	0.000604	0.00731	CcSEcCtD
Thioridazine—CHRM2—telencephalon—Alzheimer's disease	0.000601	0.00944	CbGeAlD
Thioridazine—HTR2A—blood vessel—Alzheimer's disease	0.000599	0.00941	CbGeAlD
Thioridazine—HTR6—nervous system—Alzheimer's disease	0.000592	0.00929	CbGeAlD
Thioridazine—HTR2C—telencephalon—Alzheimer's disease	0.000579	0.0091	CbGeAlD
Thioridazine—Arrhythmia—Galantamine—Alzheimer's disease	0.000573	0.00692	CcSEcCtD
Thioridazine—HTR6—central nervous system—Alzheimer's disease	0.00057	0.00895	CbGeAlD
Thioridazine—Weight increased—Donepezil—Alzheimer's disease	0.000565	0.00683	CcSEcCtD
Thioridazine—Asthma—Memantine—Alzheimer's disease	0.000563	0.00681	CcSEcCtD
Thioridazine—Mental disorder—Galantamine—Alzheimer's disease	0.000561	0.00679	CcSEcCtD
Thioridazine—Sweating increased—Memantine—Alzheimer's disease	0.000549	0.00664	CcSEcCtD
Thioridazine—Jaundice—Donepezil—Alzheimer's disease	0.000539	0.00652	CcSEcCtD
Thioridazine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000537	0.00649	CcSEcCtD
Thioridazine—Pancytopenia—Memantine—Alzheimer's disease	0.000535	0.00647	CcSEcCtD
Thioridazine—HTR1A—forebrain—Alzheimer's disease	0.00053	0.00833	CbGeAlD
Thioridazine—Vision blurred—Galantamine—Alzheimer's disease	0.000526	0.00636	CcSEcCtD
Thioridazine—Tremor—Galantamine—Alzheimer's disease	0.000523	0.00632	CcSEcCtD
Thioridazine—Anaemia—Galantamine—Alzheimer's disease	0.000516	0.00624	CcSEcCtD
Thioridazine—Weight increased—Memantine—Alzheimer's disease	0.000513	0.0062	CcSEcCtD
Thioridazine—Agitation—Galantamine—Alzheimer's disease	0.000513	0.0062	CcSEcCtD
Thioridazine—HTR7—forebrain—Alzheimer's disease	0.000507	0.00796	CbGeAlD
Thioridazine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000503	0.00608	CcSEcCtD
Thioridazine—Weight increased—Rivastigmine—Alzheimer's disease	0.000502	0.00607	CcSEcCtD
Thioridazine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000491	0.00594	CcSEcCtD
Thioridazine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000489	0.00592	CcSEcCtD
Thioridazine—ADRA1A—forebrain—Alzheimer's disease	0.000489	0.00768	CbGeAlD
Thioridazine—HTR1A—telencephalon—Alzheimer's disease	0.000488	0.00766	CbGeAlD
Thioridazine—DRD2—forebrain—Alzheimer's disease	0.000479	0.00752	CbGeAlD
Thioridazine—ADRA1B—nervous system—Alzheimer's disease	0.000472	0.00742	CbGeAlD
Thioridazine—KCNH2—forebrain—Alzheimer's disease	0.000472	0.00741	CbGeAlD
Thioridazine—Agranulocytosis—Memantine—Alzheimer's disease	0.000469	0.00567	CcSEcCtD
Thioridazine—HTR7—telencephalon—Alzheimer's disease	0.000466	0.00732	CbGeAlD
Thioridazine—Confusional state—Galantamine—Alzheimer's disease	0.000459	0.00555	CcSEcCtD
Thioridazine—ADRA1B—central nervous system—Alzheimer's disease	0.000455	0.00714	CbGeAlD
Thioridazine—HTR6—brain—Alzheimer's disease	0.000452	0.0071	CbGeAlD
Thioridazine—ADRA1A—telencephalon—Alzheimer's disease	0.00045	0.00706	CbGeAlD
Thioridazine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000446	0.00539	CcSEcCtD
Thioridazine—Tachycardia—Galantamine—Alzheimer's disease	0.000444	0.00537	CcSEcCtD
Thioridazine—Oedema peripheral—Memantine—Alzheimer's disease	0.000444	0.00537	CcSEcCtD
Thioridazine—Arrhythmia—Donepezil—Alzheimer's disease	0.000444	0.00537	CcSEcCtD
Thioridazine—DRD2—telencephalon—Alzheimer's disease	0.000441	0.00692	CbGeAlD
Thioridazine—DRD1—nervous system—Alzheimer's disease	0.00044	0.00691	CbGeAlD
Thioridazine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00044	0.00532	CcSEcCtD
Thioridazine—Mental disorder—Donepezil—Alzheimer's disease	0.000435	0.00526	CcSEcCtD
Thioridazine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000435	0.00526	CcSEcCtD
Thioridazine—KCNH2—telencephalon—Alzheimer's disease	0.000434	0.00682	CbGeAlD
Thioridazine—Anorexia—Galantamine—Alzheimer's disease	0.000434	0.00525	CcSEcCtD
Thioridazine—Erythema—Donepezil—Alzheimer's disease	0.000432	0.00523	CcSEcCtD
Thioridazine—Hypotension—Galantamine—Alzheimer's disease	0.000425	0.00515	CcSEcCtD
Thioridazine—DRD1—central nervous system—Alzheimer's disease	0.000424	0.00666	CbGeAlD
Thioridazine—Vision blurred—Donepezil—Alzheimer's disease	0.000407	0.00493	CcSEcCtD
Thioridazine—Tremor—Donepezil—Alzheimer's disease	0.000405	0.0049	CcSEcCtD
Thioridazine—Somnolence—Galantamine—Alzheimer's disease	0.000405	0.00489	CcSEcCtD
Thioridazine—Arrhythmia—Memantine—Alzheimer's disease	0.000403	0.00487	CcSEcCtD
Thioridazine—Anaemia—Donepezil—Alzheimer's disease	0.0004	0.00483	CcSEcCtD
Thioridazine—Agitation—Donepezil—Alzheimer's disease	0.000397	0.0048	CcSEcCtD
Thioridazine—Decreased appetite—Galantamine—Alzheimer's disease	0.000396	0.00479	CcSEcCtD
Thioridazine—Mental disorder—Memantine—Alzheimer's disease	0.000395	0.00478	CcSEcCtD
Thioridazine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000394	0.00477	CcSEcCtD
Thioridazine—Constipation—Galantamine—Alzheimer's disease	0.000389	0.00471	CcSEcCtD
Thioridazine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000387	0.00467	CcSEcCtD
Thioridazine—Erythema—Rivastigmine—Alzheimer's disease	0.000384	0.00464	CcSEcCtD
Thioridazine—HRH1—forebrain—Alzheimer's disease	0.000378	0.00594	CbGeAlD
Thioridazine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000375	0.00454	CcSEcCtD
Thioridazine—ADRA2A—forebrain—Alzheimer's disease	0.000372	0.00584	CbGeAlD
Thioridazine—Vision blurred—Memantine—Alzheimer's disease	0.00037	0.00447	CcSEcCtD
Thioridazine—Tremor—Memantine—Alzheimer's disease	0.000368	0.00445	CcSEcCtD
Thioridazine—Anaemia—Memantine—Alzheimer's disease	0.000363	0.00439	CcSEcCtD
Thioridazine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000362	0.00438	CcSEcCtD
Thioridazine—ADRA1B—brain—Alzheimer's disease	0.000361	0.00567	CbGeAlD
Thioridazine—Agitation—Memantine—Alzheimer's disease	0.000361	0.00436	CcSEcCtD
Thioridazine—Body temperature increased—Galantamine—Alzheimer's disease	0.00036	0.00435	CcSEcCtD
Thioridazine—Tremor—Rivastigmine—Alzheimer's disease	0.00036	0.00435	CcSEcCtD
Thioridazine—HTR2A—embryo—Alzheimer's disease	0.000357	0.00561	CbGeAlD
Thioridazine—Confusional state—Donepezil—Alzheimer's disease	0.000356	0.0043	CcSEcCtD
Thioridazine—Anaemia—Rivastigmine—Alzheimer's disease	0.000355	0.00429	CcSEcCtD
Thioridazine—CHRM2—nervous system—Alzheimer's disease	0.000355	0.00557	CbGeAlD
Thioridazine—Agitation—Rivastigmine—Alzheimer's disease	0.000353	0.00427	CcSEcCtD
Thioridazine—Oedema—Donepezil—Alzheimer's disease	0.000353	0.00427	CcSEcCtD
Thioridazine—Leukopenia—Memantine—Alzheimer's disease	0.000351	0.00425	CcSEcCtD
Thioridazine—HRH1—telencephalon—Alzheimer's disease	0.000348	0.00546	CbGeAlD
Thioridazine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000346	0.00418	CcSEcCtD
Thioridazine—HTR2C—nervous system—Alzheimer's disease	0.000342	0.00537	CbGeAlD
Thioridazine—ADRA2A—telencephalon—Alzheimer's disease	0.000342	0.00537	CbGeAlD
Thioridazine—CHRM2—central nervous system—Alzheimer's disease	0.000342	0.00536	CbGeAlD
Thioridazine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000341	0.00413	CcSEcCtD
Thioridazine—DRD1—brain—Alzheimer's disease	0.000337	0.00528	CbGeAlD
Thioridazine—Anorexia—Donepezil—Alzheimer's disease	0.000336	0.00407	CcSEcCtD
Thioridazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000335	0.00406	CcSEcCtD
Thioridazine—CYP2E1—telencephalon—Alzheimer's disease	0.000334	0.00525	CbGeAlD
Thioridazine—Hypotension—Donepezil—Alzheimer's disease	0.00033	0.00399	CcSEcCtD
Thioridazine—HTR2C—central nervous system—Alzheimer's disease	0.000329	0.00517	CbGeAlD
Thioridazine—Confusional state—Memantine—Alzheimer's disease	0.000323	0.00391	CcSEcCtD
Thioridazine—Oedema—Memantine—Alzheimer's disease	0.00032	0.00387	CcSEcCtD
Thioridazine—HTR2A—forebrain—Alzheimer's disease	0.000316	0.00496	CbGeAlD
Thioridazine—Confusional state—Rivastigmine—Alzheimer's disease	0.000316	0.00382	CcSEcCtD
Thioridazine—Somnolence—Donepezil—Alzheimer's disease	0.000314	0.00379	CcSEcCtD
Thioridazine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000314	0.00379	CcSEcCtD
Thioridazine—Oedema—Rivastigmine—Alzheimer's disease	0.000313	0.00379	CcSEcCtD
Thioridazine—Tachycardia—Memantine—Alzheimer's disease	0.000313	0.00378	CcSEcCtD
Thioridazine—Diarrhoea—Galantamine—Alzheimer's disease	0.000312	0.00377	CcSEcCtD
Thioridazine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00031	0.00375	CcSEcCtD
Thioridazine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000307	0.00371	CcSEcCtD
Thioridazine—Decreased appetite—Donepezil—Alzheimer's disease	0.000307	0.00371	CcSEcCtD
Thioridazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000306	0.0037	CcSEcCtD
Thioridazine—Anorexia—Memantine—Alzheimer's disease	0.000305	0.00369	CcSEcCtD
Thioridazine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000303	0.00366	CcSEcCtD
Thioridazine—Constipation—Donepezil—Alzheimer's disease	0.000302	0.00365	CcSEcCtD
Thioridazine—Hypotension—Memantine—Alzheimer's disease	0.000299	0.00362	CcSEcCtD
Thioridazine—Anorexia—Rivastigmine—Alzheimer's disease	0.000299	0.00361	CcSEcCtD
Thioridazine—Hypotension—Rivastigmine—Alzheimer's disease	0.000293	0.00354	CcSEcCtD
Thioridazine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000291	0.00352	CcSEcCtD
Thioridazine—HTR2A—telencephalon—Alzheimer's disease	0.000291	0.00456	CbGeAlD
Thioridazine—Vomiting—Galantamine—Alzheimer's disease	0.00029	0.0035	CcSEcCtD
Thioridazine—CYP2D6—forebrain—Alzheimer's disease	0.000288	0.00452	CbGeAlD
Thioridazine—HTR1A—nervous system—Alzheimer's disease	0.000288	0.00452	CbGeAlD
Thioridazine—Rash—Galantamine—Alzheimer's disease	0.000287	0.00347	CcSEcCtD
Thioridazine—Dermatitis—Galantamine—Alzheimer's disease	0.000287	0.00347	CcSEcCtD
Thioridazine—Headache—Galantamine—Alzheimer's disease	0.000285	0.00345	CcSEcCtD
Thioridazine—Somnolence—Memantine—Alzheimer's disease	0.000285	0.00344	CcSEcCtD
Thioridazine—Body temperature increased—Donepezil—Alzheimer's disease	0.000279	0.00337	CcSEcCtD
Thioridazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000279	0.00337	CcSEcCtD
Thioridazine—Decreased appetite—Memantine—Alzheimer's disease	0.000279	0.00337	CcSEcCtD
Thioridazine—HTR1A—central nervous system—Alzheimer's disease	0.000277	0.00435	CbGeAlD
Thioridazine—HTR7—nervous system—Alzheimer's disease	0.000275	0.00432	CbGeAlD
Thioridazine—Constipation—Memantine—Alzheimer's disease	0.000274	0.00331	CcSEcCtD
Thioridazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000272	0.00329	CcSEcCtD
Thioridazine—CHRM2—brain—Alzheimer's disease	0.000271	0.00426	CbGeAlD
Thioridazine—HTR1A—cerebellum—Alzheimer's disease	0.000271	0.00425	CbGeAlD
Thioridazine—Nausea—Galantamine—Alzheimer's disease	0.00027	0.00327	CcSEcCtD
Thioridazine—Constipation—Rivastigmine—Alzheimer's disease	0.000268	0.00324	CcSEcCtD
Thioridazine—ADRA1A—nervous system—Alzheimer's disease	0.000265	0.00417	CbGeAlD
Thioridazine—HTR7—central nervous system—Alzheimer's disease	0.000265	0.00416	CbGeAlD
Thioridazine—CYP2D6—telencephalon—Alzheimer's disease	0.000265	0.00416	CbGeAlD
Thioridazine—Feeling abnormal—Memantine—Alzheimer's disease	0.000264	0.00319	CcSEcCtD
Thioridazine—HTR2C—brain—Alzheimer's disease	0.000261	0.0041	CbGeAlD
Thioridazine—DRD2—nervous system—Alzheimer's disease	0.00026	0.00408	CbGeAlD
Thioridazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00026	0.00314	CcSEcCtD
Thioridazine—HTR7—cerebellum—Alzheimer's disease	0.000259	0.00406	CbGeAlD
Thioridazine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000258	0.00312	CcSEcCtD
Thioridazine—KCNH2—nervous system—Alzheimer's disease	0.000256	0.00402	CbGeAlD
Thioridazine—ADRA1A—central nervous system—Alzheimer's disease	0.000256	0.00401	CbGeAlD
Thioridazine—Body temperature increased—Memantine—Alzheimer's disease	0.000253	0.00306	CcSEcCtD
Thioridazine—DRD2—central nervous system—Alzheimer's disease	0.00025	0.00393	CbGeAlD
Thioridazine—ADRA1A—cerebellum—Alzheimer's disease	0.00025	0.00392	CbGeAlD
Thioridazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000248	0.003	CcSEcCtD
Thioridazine—KCNH2—central nervous system—Alzheimer's disease	0.000247	0.00387	CbGeAlD
Thioridazine—DRD2—cerebellum—Alzheimer's disease	0.000245	0.00384	CbGeAlD
Thioridazine—Diarrhoea—Donepezil—Alzheimer's disease	0.000241	0.00292	CcSEcCtD
Thioridazine—KCNH2—cerebellum—Alzheimer's disease	0.000241	0.00379	CbGeAlD
Thioridazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000236	0.00285	CcSEcCtD
Thioridazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000231	0.00279	CcSEcCtD
Thioridazine—Zuclopenthixol—HTR6—Alzheimer's disease	0.000229	0.0531	CrCbGaD
Thioridazine—Vomiting—Donepezil—Alzheimer's disease	0.000224	0.00271	CcSEcCtD
Thioridazine—Rash—Donepezil—Alzheimer's disease	0.000222	0.00269	CcSEcCtD
Thioridazine—Dermatitis—Donepezil—Alzheimer's disease	0.000222	0.00269	CcSEcCtD
Thioridazine—Headache—Donepezil—Alzheimer's disease	0.000221	0.00267	CcSEcCtD
Thioridazine—HTR1A—brain—Alzheimer's disease	0.00022	0.00345	CbGeAlD
Thioridazine—Diarrhoea—Memantine—Alzheimer's disease	0.000219	0.00265	CcSEcCtD
Thioridazine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000214	0.00259	CcSEcCtD
Thioridazine—HTR7—brain—Alzheimer's disease	0.00021	0.0033	CbGeAlD
Thioridazine—Nausea—Donepezil—Alzheimer's disease	0.00021	0.00253	CcSEcCtD
Thioridazine—HRH1—nervous system—Alzheimer's disease	0.000205	0.00323	CbGeAlD
Thioridazine—Vomiting—Memantine—Alzheimer's disease	0.000204	0.00246	CcSEcCtD
Thioridazine—ADRA1A—brain—Alzheimer's disease	0.000203	0.00318	CbGeAlD
Thioridazine—Rash—Memantine—Alzheimer's disease	0.000202	0.00244	CcSEcCtD
Thioridazine—Dermatitis—Memantine—Alzheimer's disease	0.000202	0.00244	CcSEcCtD
Thioridazine—ADRA2A—nervous system—Alzheimer's disease	0.000202	0.00317	CbGeAlD
Thioridazine—Headache—Memantine—Alzheimer's disease	0.000201	0.00243	CcSEcCtD
Thioridazine—Vomiting—Rivastigmine—Alzheimer's disease	0.000199	0.00241	CcSEcCtD
Thioridazine—DRD2—brain—Alzheimer's disease	0.000199	0.00312	CbGeAlD
Thioridazine—HRH1—central nervous system—Alzheimer's disease	0.000198	0.00311	CbGeAlD
Thioridazine—Rash—Rivastigmine—Alzheimer's disease	0.000198	0.00239	CcSEcCtD
Thioridazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000197	0.00239	CcSEcCtD
Thioridazine—CYP2E1—nervous system—Alzheimer's disease	0.000197	0.0031	CbGeAlD
Thioridazine—Thiothixene—HTR6—Alzheimer's disease	0.000197	0.0458	CrCbGaD
Thioridazine—Headache—Rivastigmine—Alzheimer's disease	0.000196	0.00237	CcSEcCtD
Thioridazine—KCNH2—brain—Alzheimer's disease	0.000196	0.00308	CbGeAlD
Thioridazine—Mesoridazine—HTR6—Alzheimer's disease	0.000195	0.0452	CrCbGaD
Thioridazine—ADRA2A—central nervous system—Alzheimer's disease	0.000194	0.00305	CbGeAlD
Thioridazine—Nausea—Memantine—Alzheimer's disease	0.00019	0.0023	CcSEcCtD
Thioridazine—CYP2E1—central nervous system—Alzheimer's disease	0.00019	0.00298	CbGeAlD
Thioridazine—ADRA2A—cerebellum—Alzheimer's disease	0.00019	0.00298	CbGeAlD
Thioridazine—Fluphenazine—CALM1—Alzheimer's disease	0.000189	0.0439	CrCbGaD
Thioridazine—Nausea—Rivastigmine—Alzheimer's disease	0.000186	0.00225	CcSEcCtD
Thioridazine—CYP2E1—cerebellum—Alzheimer's disease	0.000186	0.00292	CbGeAlD
Thioridazine—CYP2C8—brain—Alzheimer's disease	0.000179	0.00281	CbGeAlD
Thioridazine—HTR2A—nervous system—Alzheimer's disease	0.000172	0.00269	CbGeAlD
Thioridazine—Fluphenazine—HTR6—Alzheimer's disease	0.00017	0.0396	CrCbGaD
Thioridazine—HTR2A—central nervous system—Alzheimer's disease	0.000165	0.00259	CbGeAlD
Thioridazine—HTR2A—cerebellum—Alzheimer's disease	0.000161	0.00253	CbGeAlD
Thioridazine—HRH1—brain—Alzheimer's disease	0.000157	0.00247	CbGeAlD
Thioridazine—Encainide—CYP2D6—Alzheimer's disease	0.000157	0.0364	CrCbGaD
Thioridazine—CYP2D6—nervous system—Alzheimer's disease	0.000156	0.00245	CbGeAlD
Thioridazine—Clomipramine—HTR6—Alzheimer's disease	0.000156	0.0362	CrCbGaD
Thioridazine—ADRA2A—brain—Alzheimer's disease	0.000154	0.00242	CbGeAlD
Thioridazine—Promethazine—CALM1—Alzheimer's disease	0.000153	0.0356	CrCbGaD
Thioridazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000151	0.0351	CrCbGaD
Thioridazine—CYP2E1—brain—Alzheimer's disease	0.000151	0.00237	CbGeAlD
Thioridazine—CYP2D6—central nervous system—Alzheimer's disease	0.00015	0.00236	CbGeAlD
Thioridazine—Perphenazine—CALM1—Alzheimer's disease	0.000149	0.0347	CrCbGaD
Thioridazine—CYP2D6—cerebellum—Alzheimer's disease	0.000147	0.00231	CbGeAlD
Thioridazine—Trifluoperazine—HTR6—Alzheimer's disease	0.000136	0.0316	CrCbGaD
Thioridazine—Perphenazine—HTR6—Alzheimer's disease	0.000135	0.0313	CrCbGaD
Thioridazine—Ethopropazine—BCHE—Alzheimer's disease	0.000133	0.0308	CrCbGaD
Thioridazine—HTR2A—brain—Alzheimer's disease	0.000131	0.00206	CbGeAlD
Thioridazine—CYP2D6—brain—Alzheimer's disease	0.000119	0.00188	CbGeAlD
Thioridazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000119	0.0275	CrCbGaD
Thioridazine—Clemastine—CYP2D6—Alzheimer's disease	0.000116	0.0271	CrCbGaD
Thioridazine—Eletriptan—PTGS1—Alzheimer's disease	0.000116	0.0268	CrCbGaD
Thioridazine—Triflupromazine—BCHE—Alzheimer's disease	0.000109	0.0252	CrCbGaD
Thioridazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000107	0.0248	CrCbGaD
Thioridazine—Cyamemazine—HTR2A—Alzheimer's disease	9.39e-05	0.0218	CrCbGaD
Thioridazine—Eletriptan—CYP2D6—Alzheimer's disease	7.87e-05	0.0183	CrCbGaD
Thioridazine—Mequitazine—CYP2D6—Alzheimer's disease	7.46e-05	0.0173	CrCbGaD
Thioridazine—Zuclopenthixol—HTR2A—Alzheimer's disease	6.73e-05	0.0156	CrCbGaD
Thioridazine—Zuclopenthixol—CYP2D6—Alzheimer's disease	6.15e-05	0.0143	CrCbGaD
Thioridazine—Acepromazine—HTR2A—Alzheimer's disease	6.03e-05	0.014	CrCbGaD
Thioridazine—Clomipramine—SLC6A4—Alzheimer's disease	5.97e-05	0.0139	CrCbGaD
Thioridazine—Thioproperazine—HTR2A—Alzheimer's disease	5.9e-05	0.0137	CrCbGaD
Thioridazine—Thiothixene—HTR2A—Alzheimer's disease	5.8e-05	0.0135	CrCbGaD
Thioridazine—Pipotiazine—HTR2A—Alzheimer's disease	5.8e-05	0.0135	CrCbGaD
Thioridazine—Mesoridazine—HTR2A—Alzheimer's disease	5.73e-05	0.0133	CrCbGaD
Thioridazine—Thiothixene—CYP2D6—Alzheimer's disease	5.3e-05	0.0123	CrCbGaD
Thioridazine—Pipotiazine—CYP2D6—Alzheimer's disease	5.3e-05	0.0123	CrCbGaD
Thioridazine—Chlorpromazine—BCHE—Alzheimer's disease	5.24e-05	0.0122	CrCbGaD
Thioridazine—Mesoridazine—CYP2D6—Alzheimer's disease	5.24e-05	0.0122	CrCbGaD
Thioridazine—Prochlorperazine—CYP2D6—Alzheimer's disease	5.07e-05	0.0118	CrCbGaD
Thioridazine—Fluphenazine—HTR2A—Alzheimer's disease	5.01e-05	0.0116	CrCbGaD
Thioridazine—Propiomazine—HTR2A—Alzheimer's disease	4.82e-05	0.0112	CrCbGaD
Thioridazine—Clomipramine—HTR2A—Alzheimer's disease	4.59e-05	0.0106	CrCbGaD
Thioridazine—Fluphenazine—CYP2D6—Alzheimer's disease	4.58e-05	0.0106	CrCbGaD
Thioridazine—Clomipramine—CYP2D6—Alzheimer's disease	4.19e-05	0.00974	CrCbGaD
Thioridazine—Methotrimeprazine—HTR2A—Alzheimer's disease	4.12e-05	0.00958	CrCbGaD
Thioridazine—Promethazine—HTR2A—Alzheimer's disease	4.06e-05	0.00943	CrCbGaD
Thioridazine—Trifluoperazine—HTR2A—Alzheimer's disease	4.01e-05	0.00931	CrCbGaD
Thioridazine—Perphenazine—HTR2A—Alzheimer's disease	3.96e-05	0.00921	CrCbGaD
Thioridazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	3.77e-05	0.00876	CrCbGaD
Thioridazine—Promethazine—CYP2D6—Alzheimer's disease	3.72e-05	0.00863	CrCbGaD
Thioridazine—Perphenazine—CYP2D6—Alzheimer's disease	3.63e-05	0.00842	CrCbGaD
Thioridazine—Promazine—HTR2A—Alzheimer's disease	3.57e-05	0.0083	CrCbGaD
Thioridazine—Chlorpromazine—HTR2A—Alzheimer's disease	3.15e-05	0.0073	CrCbGaD
Thioridazine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.88e-05	0.00668	CrCbGaD
Thioridazine—DRD2—Signaling Pathways—F2—Alzheimer's disease	3.46e-06	5.13e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	3.45e-06	5.12e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.44e-06	5.11e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	3.44e-06	5.11e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	3.44e-06	5.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.43e-06	5.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.42e-06	5.07e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	3.42e-06	5.07e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.4e-06	5.05e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.4e-06	5.04e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	3.4e-06	5.04e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—F2—Alzheimer's disease	3.39e-06	5.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.38e-06	5.02e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	3.38e-06	5.02e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	3.37e-06	5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—INS—Alzheimer's disease	3.35e-06	4.98e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.35e-06	4.97e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.35e-06	4.97e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	3.34e-06	4.96e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	3.34e-06	4.96e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.34e-06	4.95e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.33e-06	4.95e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.33e-06	4.95e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	3.33e-06	4.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.33e-06	4.94e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.32e-06	4.93e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.32e-06	4.93e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.32e-06	4.92e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.31e-06	4.91e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	3.3e-06	4.89e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.29e-06	4.89e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	3.29e-06	4.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.29e-06	4.89e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	3.29e-06	4.88e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	3.29e-06	4.88e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	3.28e-06	4.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.28e-06	4.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.28e-06	4.87e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.27e-06	4.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.26e-06	4.84e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.25e-06	4.83e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	3.17e-06	4.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	3.15e-06	4.67e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.14e-06	4.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.13e-06	4.65e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—INS—Alzheimer's disease	3.13e-06	4.65e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	3.13e-06	4.64e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	3.13e-06	4.64e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.12e-06	4.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.12e-06	4.63e-05	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.12e-06	4.63e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—APOE—Alzheimer's disease	3.12e-06	4.62e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.11e-06	4.62e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.1e-06	4.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.09e-06	4.59e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.09e-06	4.59e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.09e-06	4.58e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	3.09e-06	4.58e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.08e-06	4.57e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.08e-06	4.57e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—INS—Alzheimer's disease	3.08e-06	4.57e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.07e-06	4.56e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.07e-06	4.55e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	3.07e-06	4.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.06e-06	4.54e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.05e-06	4.53e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	3.04e-06	4.52e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	3.04e-06	4.51e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	3.04e-06	4.51e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.03e-06	4.5e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.03e-06	4.5e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.03e-06	4.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.03e-06	4.49e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	3.03e-06	4.49e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.03e-06	4.49e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.02e-06	4.49e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.02e-06	4.48e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.99e-06	4.43e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.98e-06	4.42e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.98e-06	4.42e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.98e-06	4.42e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.97e-06	4.41e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.97e-06	4.41e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.94e-06	4.36e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.93e-06	4.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.92e-06	4.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.84e-06	4.22e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.84e-06	4.21e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.84e-06	4.21e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.83e-06	4.2e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.83e-06	4.19e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.82e-06	4.18e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.8e-06	4.16e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.79e-06	4.15e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	2.79e-06	4.14e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.79e-06	4.14e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.78e-06	4.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.76e-06	4.09e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.75e-06	4.09e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.75e-06	4.08e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.75e-06	4.08e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.72e-06	4.04e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.71e-06	4.03e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.71e-06	4.02e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.7e-06	4.01e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.7e-06	4.01e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.7e-06	4e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.69e-06	3.99e-05	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.68e-06	3.98e-05	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.67e-06	3.96e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—INS—Alzheimer's disease	2.66e-06	3.95e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.66e-06	3.94e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.65e-06	3.94e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.65e-06	3.93e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.64e-06	3.92e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.64e-06	3.92e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.62e-06	3.9e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.62e-06	3.89e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.58e-06	3.84e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.57e-06	3.81e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.56e-06	3.8e-05	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.55e-06	3.79e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.54e-06	3.78e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.54e-06	3.76e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.53e-06	3.76e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.53e-06	3.75e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.51e-06	3.73e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.51e-06	3.73e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	2.47e-06	3.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.46e-06	3.65e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.44e-06	3.62e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.43e-06	3.61e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.43e-06	3.6e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.42e-06	3.59e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.42e-06	3.59e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.41e-06	3.57e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—INS—Alzheimer's disease	2.38e-06	3.52e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.35e-06	3.49e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.33e-06	3.46e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.33e-06	3.46e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.33e-06	3.45e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.32e-06	3.45e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.32e-06	3.44e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.32e-06	3.44e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.32e-06	3.44e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.31e-06	3.43e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	2.3e-06	3.41e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	2.3e-06	3.41e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.29e-06	3.4e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.29e-06	3.4e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.28e-06	3.38e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.27e-06	3.38e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.27e-06	3.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.27e-06	3.36e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.25e-06	3.34e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.25e-06	3.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.25e-06	3.33e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.24e-06	3.33e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.24e-06	3.32e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.23e-06	3.31e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.23e-06	3.31e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.21e-06	3.28e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.18e-06	3.24e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.17e-06	3.23e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.17e-06	3.21e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.17e-06	3.21e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.15e-06	3.19e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.15e-06	3.18e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.14e-06	3.18e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.14e-06	3.17e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.13e-06	3.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.11e-06	3.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.11e-06	3.13e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	2.11e-06	3.12e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.1e-06	3.12e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	2.1e-06	3.12e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.1e-06	3.12e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.1e-06	3.11e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.09e-06	3.1e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.08e-06	3.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.07e-06	3.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.07e-06	3.07e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.07e-06	3.07e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.06e-06	3.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.06e-06	3.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.06e-06	3.06e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.06e-06	3.05e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.98e-06	2.94e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	2.94e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.97e-06	2.92e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.95e-06	2.89e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.94e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.94e-06	2.88e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.92e-06	2.85e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.92e-06	2.84e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.91e-06	2.84e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.91e-06	2.84e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.91e-06	2.83e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.91e-06	2.83e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.9e-06	2.82e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.89e-06	2.8e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.85e-06	2.75e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	2.69e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.81e-06	2.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.79e-06	2.65e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	2.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.77e-06	2.63e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.75e-06	2.6e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	2.6e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.75e-06	2.6e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.74e-06	2.58e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.7e-06	2.53e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.69e-06	2.51e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.67e-06	2.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	2.41e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.62e-06	2.41e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	2.41e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.56e-06	2.31e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.55e-06	2.3e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	2.22e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.48e-06	2.2e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.48e-06	2.2e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	2.18e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.44e-06	2.14e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.44e-06	2.14e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.44e-06	2.13e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.43e-06	2.12e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	2.03e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	2.03e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.35e-06	2.01e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.35e-06	2e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	1.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	1.99e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.32e-06	1.96e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.32e-06	1.96e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	1.87e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.84e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.24e-06	1.84e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.84e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	1.82e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.22e-06	1.81e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.22e-06	1.8e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.68e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.07e-06	1.59e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9.58e-07	1.42e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.81e-07	1.31e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	8.73e-07	1.3e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	7.46e-07	1.11e-05	CbGpPWpGaD
